Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ELOX Eloxx Pharmaceuticals Inc

3,82

0,00 (0,00%)

14 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Eloxx Pharmaceuticals Charts.

News Eloxx Pharmaceuticals Inc

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
Dienstag 16 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Montag 1 April 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 29 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Donnerstag 21 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
Mittwoch 13 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 26 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 25 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 24 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Weitere Eloxx Pharmaceuticals Inc News-Artikel

Res.mtg 16 A2aa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen